AzTrials
AzTrials

InfertilityNCT04125017

Atrificial Shrinkage of Blastocyst Before In Vitro Fertilization

A study testing ICSI with laser pulse and ICSI with micro needle technique in people with Infertility, run by Aljazeera Hospital at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Vitrification is a modern cryopreservation technique based on sudden cooling of reproductive cells to a temperature of -196 ° C in seconds that produces glass-like solidification of a solution without crystallization, but by extreme elevation in viscosity during freezing Read more about this study

Who is it for?
Ages 20 to 44 years, women only
Conditions the study is for
Infertility
What is being tested?
ICSI with laser pulse and ICSI with micro needle technique
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
409 participants
Where
1 siteEgypt
Study dates
1 Jan 2019to 5 Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 44 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • women with infertility from 20 to 44 years

Who cannot join

  • women with age more than 44 or less than 20

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Adam

    Giza

Other trials in Egypt

About this study

Official title: Comparative Study Between Two Techniques for Artificial Shrinkage of Blastocysts Prior to Vitrification: LASER Pulse Versus Micro-needle Technique in Increasing Chemical, Clinical Pregnancy and Live Birth Rates After ICSI

Vitrification is a modern cryopreservation technique based on sudden cooling of reproductive cells to a temperature of -196 ° C in seconds that produces glass-like solidification of a solution without crystallization, but by extreme elevation in viscosity during freezing

Read the detailed description

Vitrification is a modern cryopreservation technique based on sudden cooling of reproductive cells to a temperature of -196 ° C in seconds that produces glass-like solidification of a solution without crystallization, but by extreme elevation in viscosity during freezing Unlike the slow freezing method, vitrification has better results in a complete elimination of ice crystal inside the cells as well as in the surrounding solution -Also, it has a significantly higher post-thawing survival rate in comparison to slow freezing method

Conditions
Infertility
Being tested
ICSI with laser pulse, ICSI with micro needle technique
Medical subject headings
Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ICSI with laser pulseDevice

    Using laser pulse before ICSI

  • ICSI with micro needle techniqueDevice

    Using micro needle technique before ICSI

Study groups in NCT04125017
Study groupRoleWhat they receive
effect of using LASER pulseOthereffect of using LASER pulse versus micro-needle use in the artificial shrinkage of blastocysts as a previous step before vitrification in regarding their effect on embryo viability
Receives: Device: ICSI with laser pulse; Device: ICSI with micro needle technique
Micro-needle TechniqueOthereffect of using LASER pulse versus micro-needle use in the artificial shrinkage of blastocysts as a previous step before vitrification in regarding their effect on embryo viability
Receives: Device: ICSI with laser pulse; Device: ICSI with micro needle technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of women who will have positive pregnancy test

    The number of women who will come pregnant after each technique

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2019
  2. Study start1 Jan 2019
  3. Primary completion4 Jan 2020
  4. Study completion5 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
effect of using LASER pulse versus micro-needle use in the artificial shrinkage of blastocysts .
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
409 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04125017
Sponsor's protocol ID
blastocyst preparation
Status last verified
Oct 2023
First submitted
10 Oct 2019
Last updated
10 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Kamel Mohamed M, El-Noury MAH, Amer MK, Fakhry E, Alalfy M. Comparative study between two techniques for artificial shrinkage of blastocysts prior to vitrification: LASER pulse versus micro-needle technique in increasing chemical, clinical pregnancy and live birth rates after ICSI, a randomized controlled trial. J Matern Fetal Neonatal Med. 2022 Dec;35(25):4910-4917. doi: 10.1080/14767058.2021.1873265. Epub 2021 Feb 28.

    PubMed 33645399

Questions about this trial

What is this clinical trial studying?

A study testing ICSI with laser pulse and ICSI with micro needle technique in people with Infertility, run by Aljazeera Hospital at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of women who will have positive pregnancy test (time frame: 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04125017, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in